MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in MoonLake Immunotherapeutics as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +4 vs. Q1 2021
- Shares held
- 11.2M
- +526.2K (+4.9%) vs. Q1 2021
- Total value
- $115.8M
- +$6.86M (+6.3%) vs. Q1 2021
- New holders
- 6
- 7 more added
- Sold out
- 2
- 9 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 17 | $0 | 0.00% | +17 | New |
| UBS Group AG | 374 | $4.00K | 0.00% | +374 | New |
| Morgan Stanley | 5,900 | $61.0K | 0.00% | −10.0% | Reduced |
| Panagora Asset Management Inc | 7,212 | $74.0K | 0.00% | −41−0.6% | Reduced |
| HRT Financial LP | 14,258 | $147.0K | 0.00% | 00.0% | Unchanged |
| Caxton Corp | 16,009 | $165.0K | 0.11% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 23,013 | $238.0K | 0.00% | +23,013 | New |
| Nomura Holdings Inc | 24,949 | $255.0K | 0.00% | −51−0.2% | Reduced |
| ExodusPoint Capital Management, LP | 25,000 | $259.0K | 0.00% | 00.0% | Unchanged |
| Radcliffe Capital Management, L.P. | 25,131 | $260.0K | 0.01% | +5,131+25.7% | Added |
| Exos Asset Management LLC | 25,100 | $260.0K | 0.13% | +20,100+402.0% | Added |
| Meridian Wealth Management, LLC | 27,000 | $279.0K | 0.04% | +8,100+42.9% | Added |
| TD Asset Management Inc | 44,766 | $444.0K | 0.00% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 48,263 | $497.0K | 0.00% | 00.0% | Unchanged |
| Maven Securities LTD | 50,000 | $513.0K | 0.05% | 00.0% | Unchanged |
| Logos Global Management LP | 50,000 | $518.0K | 0.04% | −150,000−75.0% | Reduced |
| Prelude Capital Management, LLC | 50,000 | $518.0K | 0.03% | +50,000 | New |
| Millennium Management LLC | 55,735 | $577.0K | 0.00% | +35,735+178.7% | Added |
| Glazer Capital, LLC | 57,849 | $599.0K | 0.01% | +56,748+5,154.2% | Added |
| Magnetar Financial LLC | 61,204 | $632.0K | 0.01% | −2,747−4.3% | Reduced |
| Picton Mahoney Asset Management | 70,000 | $725.0K | 0.03% | +70,000 | New |
| Consonance Capital Management LP | 150,000 | $1.55M | 0.19% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 150,000 | $1.55M | 0.08% | 00.0% | Unchanged |
| BlueCrest Capital Management Ltd | 150,000 | $1.55M | 0.05% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 154,500 | $1.60M | 0.03% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 200,000 | $2.07M | 0.08% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 234,020 | $2.42M | 1.27% | +5,535+2.4% | Added |
| Tekla Capital Management LLC | 250,000 | $2.58M | 0.08% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 250,000 | $2.59M | 0.17% | 00.0% | Unchanged |
| Altium Capital Management LP | 250,000 | $2.59M | 0.60% | 00.0% | Unchanged |
| Foresite Capital Management V, LLC | 250,000 | $2.59M | 1.02% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 320,000 | $3.31M | 0.04% | 00.0% | Unchanged |
| Finepoint Capital LP | 350,000 | $3.62M | 0.68% | +350,000 | New |
| Boxer Capital, LLC | 400,000 | $4.13M | 0.15% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 400,000 | $4.13M | 0.86% | 00.0% | Unchanged |
| Avidity Partners Management LP | 400,000 | $4.14M | 0.11% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 430,000 | $4.45M | 0.17% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 500,000 | $5.17M | 1.62% | 00.0% | Unchanged |
| Staley Capital Advisers Inc | 500,000 | $5.17M | 0.27% | +200,000+66.7% | Added |
| Wellington Management Group LLP | 516,296 | $5.33M | 0.00% | −10,429−2.0% | Reduced |
| Citadel Advisors LLC | 691,731 | $7.15M | 0.01% | −1,636−0.2% | Reduced |
| Ra Capital Management, L.P. | 700,000 | $7.25M | 0.12% | 00.0% | Unchanged |
| BlackRock Inc. | 747,863 | $7.74M | 0.00% | −2,290−0.3% | Reduced |
| RTW Investments, LP | 750,000 | $7.76M | 0.12% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 756,303 | $7.81M | 0.00% | −35,982−4.5% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,011,589 | $10.5M | 0.02% | 00.0% | Unchanged |
| HealthCor Management, L.P. | 0 | $0 | 0.00% | −60,027−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −35,344−100.0% | Sold out |